GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Buildings And Improvements : ₹1,214 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Buildings And Improvements?

GlaxoSmithKline Pharmaceuticals's quarterly buildings and improvements stayed the same from Sep. 2024 (₹0 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹1,214 Mil).

GlaxoSmithKline Pharmaceuticals's annual buildings and improvements increased from Mar. 2023 (₹1,084 Mil) to Mar. 2024 (₹1,274 Mil) but then declined from Mar. 2024 (₹1,274 Mil) to Mar. 2025 (₹1,214 Mil).

GlaxoSmithKline Pharmaceuticals Buildings And Improvements Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Buildings And Improvements Chart

GlaxoSmithKline Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Buildings And Improvements

Get a 7-Day Free Trial

1,022.03

1,040.81

1,084.14

1,273.73

1,213.66

GlaxoSmithKline Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															1,273.73	-	-	-	1,213.66

GlaxoSmithKline Pharmaceuticals Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

GlaxoSmithKline Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (NSE:GLAXO) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

500660:India

Address

Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400030

Website

https://www.gsk-india.com

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.

GlaxoSmithKline Pharmaceuticals Headlines

No Headlines